Advertisement
Singapore markets close in 1 hour 19 minutes
  • Straits Times Index

    3,173.28
    -14.38 (-0.45%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,235.35
    -150.52 (-0.92%)
     
  • FTSE 100

    7,840.96
    -36.09 (-0.46%)
     
  • Bitcoin USD

    64,511.84
    +3,532.61 (+5.79%)
     
  • CMC Crypto 200

    1,330.28
    +17.65 (+1.34%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,401.70
    +3.70 (+0.15%)
     
  • Crude Oil

    83.80
    +1.07 (+1.29%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,549.79
    +5.03 (+0.33%)
     
  • Jakarta Composite Index

    7,093.59
    -73.22 (-1.02%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

How Gilead Sciences Stock Performed in the First Half of October

How Gilead Sciences Stock Performed in the First Half of October

On October 12, Gilead Sciences (GILD) closed at $73.59, which was 1.5% higher than its closing price on October 11. This increase in its stock price followed the company’s announcement that it planned to release data from its R&D programs targeting various liver conditions at The Liver Meeting 2018 in San Francisco. Its stock price dropped 1.1% and closed at $72.78 on October 15.